St. Joseph's University Medical Center, Paterson, NJ, USA.
St. George's University, Grenada.
J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241253348. doi: 10.1177/23247096241253348.
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the digestive tract and arise from the interstitial cells of Cajal in the mesenteric plexus. These tumors can originate in any part of the GI tract; however, a higher burden has been observed in the stomach and small intestines. Mesenteric GISTs are exceedingly rare, with unique clinicopathological features and a poorer prognosis. Herein, we describe a unique case of a 66-year-old female with a remote history of appendectomy who presented to the emergency room complaining of severe abdominal pain and vomiting. On imaging, the patient was found to have a large inflammatory mass associated with small bowel loops, and the pathology confirmed a mesenteric GIST. The tumor was resected, and the genomic test results confirmed the KIT (exon 11) mutation. Although the tumor had a low mitotic rate, the tumor was large enough to warrant the initiation of adjuvant imatinib mesylate for 36 months with regular bloodwork and imaging.
胃肠道间质瘤(GISTs)是消化道最常见的间叶源性肿瘤,来源于肠系膜丛的 Cajal 间质细胞。这些肿瘤可发生于胃肠道的任何部位,但胃和小肠的发病率更高。肠系膜 GIST 极为罕见,具有独特的临床病理特征和较差的预后。在此,我们描述了一例罕见病例,一名 66 岁女性,既往有阑尾切除术史,因严重腹痛和呕吐就诊于急诊科。影像学检查发现患者存在与小肠袢相关的大炎症性肿块,且病理证实为肠系膜 GIST。肿瘤被切除,基因检测结果证实存在 KIT(外显子 11)突变。尽管肿瘤的有丝分裂率较低,但肿瘤足够大,需要开始辅助甲磺酸伊马替尼治疗 36 个月,同时定期进行血液检查和影像学检查。